CONFERENCES

    Gordon Research Conferences

    Gordon Research Conferences (GRC) are a group of international scientific conferences focused on the latest developments in scientific research across various fields, with topics ranging from basic science to applied research. The conferences are aimed at researchers and other professionals involved in scientific research, and provide a forum for sharing knowledge and collaborating on new approaches to scientific discovery.

    Lipidomics Conference GRC 2022

    Date

    Aug 07, 2022 - Aug 12, 2022

    Location

    Maine, USA

    This Gordon Conference series includes presentations on the recent developments in standardization, omics integration, and state-of-the-art technologies and their impact on applications to study human health and disease.

    Cellular and Molecular Mechanisms of Toxicity GRC 2019

    Date

    Aug 11, 2019 - Aug 16, 2019

    Location

    Andover, U.S.

    The program of this conference highlights innovations and challenges in mechanistic toxicology including the human exposome, big data and quantitative systems modeling, and alternative methods in risk assessment.

    Cancer Genetics and Epigenetics GRC 2007

    Date

    May 20, 2007 - May 25, 2007

    Location

    Lucca (Barga), LU, Italy

    See related posters

    PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
    ​
    Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.